Latest Velan Capital Investment Management LP Stock Portfolio
Velan Capital Investment Management LP Performance:
2025 Q4: 36.6%YTD: 23.93%2024: 13.05%
Performance for 2025 Q4 is 36.6%, and YTD is 23.93%, and 2024 is 13.05%.
About Velan Capital Investment Management LP and 13F Hedge Fund Stock Holdings
On 2026-02-13, the fund reported it's updated stock portfolio. In the 13F Holdings report, Velan Capital Investment Management LP reported an equity portfolio of $172.4 Millions as of 31 Dec, 2025.
The top stock holdings of Velan Capital Investment Management LP are PRAX, CDTX, TARA. The fund has invested 17.2% of it's portfolio in PRAXIS PRECISION MEDICINES I and 13.9% of portfolio in CIDARA THERAPEUTICS INC.
The fund managers got completely rid off ZOOZ PWR LTD, SUTRO BIOPHARMA INC (STRO) and UNIQURE NV (QURE) stocks. They significantly reduced their stock positions in CORBUS PHARMACEUTICALS HLDGS (CRBP), PYXIS ONCOLOGY INC (PYXS) and REPLIMUNE GROUP INC (REPL). Velan Capital Investment Management LP opened new stock positions in MAPLIGHT THERAPEUTICS INC, ESPERION THERAPEUTICS INC NE (ESPR) and VERRICA PHARMACEUTICALS INC (VRCA). The fund showed a lot of confidence in some stocks as they added substantially to TERNS PHARMACEUTICALS INC (TERN), RAPT THERAPEUTICS INC (RAPT) and PROTARA THERAPEUTICS INC (TARA).
The top stock holdings of Velan Capital Investment Management LP are PRAX, CDTX, TARA. The fund has invested 17.2% of it's portfolio in PRAXIS PRECISION MEDICINES I and 13.9% of portfolio in CIDARA THERAPEUTICS INC.
The fund managers got completely rid off ZOOZ PWR LTD, SUTRO BIOPHARMA INC (STRO) and UNIQURE NV (QURE) stocks. They significantly reduced their stock positions in CORBUS PHARMACEUTICALS HLDGS (CRBP), PYXIS ONCOLOGY INC (PYXS) and REPLIMUNE GROUP INC (REPL). Velan Capital Investment Management LP opened new stock positions in MAPLIGHT THERAPEUTICS INC, ESPERION THERAPEUTICS INC NE (ESPR) and VERRICA PHARMACEUTICALS INC (VRCA). The fund showed a lot of confidence in some stocks as they added substantially to TERNS PHARMACEUTICALS INC (TERN), RAPT THERAPEUTICS INC (RAPT) and PROTARA THERAPEUTICS INC (TARA).
Velan Capital Investment Management LP Annual Return Estimates Vs S&P 500
Our best estimate is that Velan Capital Investment Management LP made a return of 36.6% in the last quarter. In trailing 12 months, it's portfolio return was 23.93%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| maplight therapeutics inc | 9,174,290 |
| evommune inc | 8,675,630 |
| esperion therapeutics inc ne | 4,477,000 |
| verrica pharmaceuticals inc | 3,918,660 |
| sutro biopharma inc | 3,609,840 |
| profound med corp | 2,248,540 |
| kazia therapeutics ltd | 2,067,000 |
| xilio therapeutics inc | 108,834 |
New stocks bought by Velan Capital Investment Management LP
Additions
| Ticker | % Inc. |
|---|---|
| terns pharmaceuticals inc | 250 |
| rapt therapeutics inc | 35.04 |
| protara therapeutics inc | 32.52 |
| abivax sa | 4.06 |
| lantheus hldgs inc | 1.55 |
Additions to existing portfolio by Velan Capital Investment Management LP
Reductions
| Ticker | % Reduced |
|---|---|
| corbus pharmaceuticals hldgs | -78.69 |
| pyxis oncology inc | -27.27 |
| replimune group inc | -25.00 |
| praxis precision medicines i | -24.11 |
| mineralys therapeutics inc | -14.01 |
Velan Capital Investment Management LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| zooz pwr ltd | -4,280,000 |
| alumis inc | -3,777,260 |
| tela bio inc | -1,113,640 |
| eledon pharmaceuticals inc | -898,660 |
| sutro biopharma inc | -2,709,410 |
| geron corp | -109,600 |
| erasca inc | -141,700 |
| alector inc | -162,800 |
Velan Capital Investment Management LP got rid off the above stocks
Sector Distribution
Velan Capital Investment Management LP has about 77.1% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 77.1 |
| Others | 22.9 |
Market Cap. Distribution
Velan Capital Investment Management LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- MID-CAP
- MICRO-CAP
- UNALLOCATED
- SMALL-CAP
- NANO-CAP
| Category | % |
|---|---|
| MID-CAP | 37.9 |
| MICRO-CAP | 26 |
| UNALLOCATED | 22.9 |
| SMALL-CAP | 9.7 |
| NANO-CAP | 3.5 |
Stocks belong to which Index?
About 23.6% of the stocks held by Velan Capital Investment Management LP either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 76.4 |
| RUSSELL 2000 | 23.6 |
Velan Capital Investment Management LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Velan Capital Investment Management LP
Velan Capital Investment Management LP has 45 stocks in it's portfolio. About 71% of the portfolio is in top 10 stocks. RZLT proved to be the most loss making stock for the portfolio. PRAX was the most profitable stock for Velan Capital Investment Management LP last quarter.
Last Reported on: 13 Feb, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACRS | aclaris therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALEC | alector inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARWR | arrowhead pharmaceuticals in | 0.25 | 6,500 | 431,535 | unchanged | 0.00 | ||
| AVTX | avalo therapeutics inc | 2.78 | 263,642 | 4,787,740 | unchanged | 0.00 | ||
| CDTX | cidara therapeutics inc | 13.89 | 108,404 | 23,945,400 | unchanged | 0.00 | ||
| CNTX | context therapeutics inc | 0.09 | 100,000 | 147,000 | unchanged | 0.00 | ||
| CRBP | corbus pharmaceuticals hldgs | 0.06 | 13,000 | 105,820 | reduced | -78.69 | ||
| CTMX | cytomx therapeutics inc | 0.20 | 80,000 | 340,800 | unchanged | 0.00 | ||
| DSGN | design therapeutics inc | 0.11 | 20,000 | 187,600 | unchanged | 0.00 | ||
| DTIL | precision biosciences inc | 0.05 | 20,000 | 83,200 | unchanged | 0.00 | ||
| EDSA | edesa biotech inc | 0.57 | 687,500 | 976,250 | unchanged | 0.00 | ||
| ELDN | eledon pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ERAS | erasca inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ESPR | esperion therapeutics inc ne | 2.60 | 1,210,000 | 4,477,000 | new | |||
| GERN | geron corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| GOSS | gossamer bio inc | 0.13 | 70,000 | 217,000 | unchanged | 0.00 | ||
| HRTX | heron therapeutics inc | 6.60 | 8,753,290 | 11,379,300 | unchanged | 0.00 | ||
| IMMX | immix biopharma inc | 0.11 | 35,000 | 183,050 | unchanged | 0.00 | ||
| IMNM | immunome inc | 0.12 | 10,000 | 214,800 | unchanged | 0.00 | ||
| JSPR | jasper therapeutics inc | 2.83 | 2,668,400 | 4,883,160 | unchanged | 0.00 | ||